NIH 'XDR-tuberculosis' case spotlights drug resistance threat
This article was originally published in Scrip
Executive Summary
The National Institutes of Health (NIH) on 8 June disclosed that a woman with extensively drug-resistant tuberculosis (XDR-TB), which is particularly difficult to treat, was admitted three days earlier to the agency's Clinical Center, where she is being treated in an isolation room.